Item Type | Name |
Academic Article
|
Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.
|
Academic Article
|
Large animal models of congestive heart failure: a critical step in translating basic observations into clinical applications.
|
Academic Article
|
Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling.
|
Academic Article
|
Modulation of calcium transport improves myocardial contractility and enzyme profiles after prolonged ischemia-reperfusion.
|
Academic Article
|
Myocyte contractility with caspase inhibition and simulated hyperkalemic cardioplegic arrest.
|
Academic Article
|
Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: relation to interstitial membrane type-1 matrix metalloproteinase activity.
|
Academic Article
|
Disruptions and detours in the myocardial matrix highway and heart failure.
|
Academic Article
|
Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation.
|
Academic Article
|
Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation.
|
Academic Article
|
Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction.
|
Academic Article
|
Protein kinase C isoform activation and endothelin-1 mediated defects in myocyte contractility after cardioplegic arrest and reperfusion.
|
Academic Article
|
Differential effects of protein kinase C isoform activation in endothelin-mediated myocyte contractile dysfunction with cardioplegic arrest and reperfusion.
|
Academic Article
|
Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves.
|
Academic Article
|
Aprotinin in cardiac surgery: a review of conventional and novel mechanisms of action.
|
Academic Article
|
Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
|
Academic Article
|
Dynamic changes in matrix metalloprotienase activity within the human myocardial interstitium during myocardial arrest and reperfusion.
|
Academic Article
|
Large animal models of heart failure: a critical link in the translation of basic science to clinical practice.
|
Academic Article
|
Pathophysiology of myocardial injury and remodeling: implications for molecular imaging.
|
Academic Article
|
Circulating matrix metalloproteinase levels after ventricular septal defect repair in infants.
|
Academic Article
|
Long-term localized high-frequency electric stimulation within the myocardial infarct: effects on matrix metalloproteinases and regional remodeling.
|
Academic Article
|
Cardiac function and circulating cytokines after endotoxin exposure in neonatal mice.
|
Academic Article
|
Amplified bioactive signaling and proteolytic enzymes following ischemia reperfusion and aging: remodeling pathways that are not like a fine wine.
|
Academic Article
|
Heterogeneity in MT1-MMP activity with ischemia-reperfusion and previous myocardial infarction: relation to regional myocardial function.
|
Academic Article
|
Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy.
|
Academic Article
|
Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure.
|
Academic Article
|
TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling.
|
Academic Article
|
Matrix metalloproteinases: regulation and dysregulation in the failing heart.
|
Academic Article
|
Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective.
|
Academic Article
|
Viscoelastic properties of pressure overload hypertrophied myocardium: effect of serine protease treatment.
|
Academic Article
|
Cardiorenal effects of adenosine subtype 1 (A1) receptor inhibition in an experimental model of heart failure.
|
Academic Article
|
Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications.
|
Academic Article
|
Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction.
|
Academic Article
|
Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery.
|
Academic Article
|
Membrane-associated matrix proteolysis and heart failure.
|
Academic Article
|
Changes in extracellular collagen matrix alter myocardial systolic performance.
|
Academic Article
|
Extracellular degradative pathways in myocardial remodeling and progression to heart failure.
|
Academic Article
|
Selective matrix metalloproteinase inhibition with developing heart failure: effects on left ventricular function and structure.
|
Academic Article
|
Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion.
|
Academic Article
|
Extracellular matrix remodeling following myocardial injury.
|
Academic Article
|
Myocardial remodeling after discrete radiofrequency injury: effects of tissue inhibitor of matrix metalloproteinase-1 gene deletion.
|
Academic Article
|
Matrix metalloproteinase gene polymorphisms in heart failure: new pieces to the myocardial matrix puzzle.
|
Academic Article
|
Duality of innate stress responses in cardiac injury, repair, and remodeling.
|
Academic Article
|
Left ventricular form and function: scientific priorities and strategic planning for development of new views of disease.
|
Academic Article
|
Caspase inhibition attenuates contractile dysfunction following cardioplegic arrest and rewarming in the setting of left ventricular failure.
|
Academic Article
|
Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition.
|
Academic Article
|
Plasma monitoring of the myocardial specific tissue inhibitor of metalloproteinase-4 after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
|
Academic Article
|
Matrix modulation and heart failure: new concepts question old beliefs.
|
Academic Article
|
Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction.
|
Academic Article
|
Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction.
|
Academic Article
|
Infarct size reduction and attenuation of global left ventricular remodeling with the CorCap cardiac support device following acute myocardial infarction in sheep.
|
Academic Article
|
Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
|
Academic Article
|
Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction.
|
Academic Article
|
Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs).
|
Academic Article
|
Interruption of endothelin signaling modifies membrane type 1 matrix metalloproteinase activity during ischemia and reperfusion.
|
Academic Article
|
Relationships between plasma levels of matrix metalloproteinases and neurohormonal profile in patients with heart failure.
|
Academic Article
|
Cardiac-restricted overexpression of extracellular matrix metalloproteinase inducer causes myocardial remodeling and dysfunction in aging mice.
|
Academic Article
|
Matrix metalloproteinase therapy in heart failure.
|
Academic Article
|
Calpain inhibition preserves myocardial structure and function following myocardial infarction.
|
Academic Article
|
Cardiac-restricted overexpression of membrane type-1 matrix metalloproteinase in mice: effects on myocardial remodeling with aging.
|
Academic Article
|
SmartDelay determined AV optimization: a comparison of AV delay methods used in cardiac resynchronization therapy (SMART-AV): rationale and design.
|
Academic Article
|
Caspase inhibition modulates left ventricular remodeling following myocardial infarction through cellular and extracellular mechanisms.
|
Academic Article
|
Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart.
|
Academic Article
|
Interstitial plasmin activity with epsilon aminocaproic acid: temporal and regional heterogeneity.
|
Academic Article
|
Alterations in membrane type-1 matrix metalloproteinase abundance after the induction of thoracic aortic aneurysm in a murine model.
|
Academic Article
|
Short-term disruption in regional left ventricular electrical conduction patterns increases interstitial matrix metalloproteinase activity.
|
Academic Article
|
Determinants of extracellular matrix remodelling are differentially expressed in paediatric and adult dilated cardiomyopathy.
|
Academic Article
|
Standardized preoperative corticosteroid treatment in neonates undergoing cardiac surgery: results from a randomized trial.
|
Academic Article
|
Direct regulation of membrane type 1 matrix metalloproteinase following myocardial infarction causes changes in survival, cardiac function, and remodeling.
|
Academic Article
|
Early postoperative outcomes and blood product utilization in adult cardiac surgery: the post-aprotinin era.
|
Academic Article
|
Changes in the myocardial interstitium and contribution to the progression of heart failure.
|
Academic Article
|
Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis.
|
Academic Article
|
Animal models of heart failure: a scientific statement from the American Heart Association.
|
Academic Article
|
Gene targeting in ischemic heart disease and failure: translational and clinical studies.
|
Academic Article
|
Epilysin (matrix metalloproteinase-28) joins the matrix metalloproteinase team on the field of postmyocardial infarction remodeling.
|
Academic Article
|
Biomarkers and heart disease: what is translational success?
|
Academic Article
|
Integrating the myocardial matrix into heart failure recognition and management.
|
Concept
|
Heart Block
|
Concept
|
Heart Valve Prosthesis Implantation
|
Concept
|
Heart Failure
|
Concept
|
Heart Defects, Congenital
|
Concept
|
Heart Rupture
|
Concept
|
Heart Septum
|
Concept
|
Heart Rate
|
Concept
|
Heart
|
Concept
|
Heart Conduction System
|
Concept
|
Heart Atria
|
Concept
|
Heart Failure, Diastolic
|
Concept
|
Heart Valve Prosthesis
|
Concept
|
Heart-Assist Devices
|
Concept
|
Heart Arrest, Induced
|
Concept
|
Heart Ventricles
|
Concept
|
Heart Valve Diseases
|
Concept
|
Heart Septal Defects
|
Concept
|
Heart Diseases
|
Concept
|
Heart Function Tests
|
Academic Article
|
Cyclosporin A in left ventricular remodeling after myocardial infarction.
|
Academic Article
|
Mechanistic relationship between membrane type-1 matrix metalloproteinase and the myocardial response to pressure overload.
|
Academic Article
|
Reply to "letter to the editor: 'cyclosporin A in left ventricular remodeling after myocardial infarction'".
|
Academic Article
|
Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors.
|
Academic Article
|
Cardiac-restricted overexpression or deletion of tissue inhibitor of matrix metalloproteinase-4: differential effects on left ventricular structure and function following pressure overload-induced hypertrophy.
|
Academic Article
|
Inhibition of class I histone deacetylase activity represses matrix metalloproteinase-2 and -9 expression and preserves LV function postmyocardial infarction.
|
Academic Article
|
Fate Versus Flow: Wall Shear Stress in the Aortopathy Associated With Bicuspid Aortic Valves.
|
Academic Article
|
Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
|
Academic Article
|
Regional and temporal changes in left ventricular strain and stiffness in a porcine model of myocardial infarction.
|
Academic Article
|
Development of a biomarker panel to predict cardiac resynchronization therapy response: Results from the SMART-AV trial.
|
Academic Article
|
Bioactive Signaling in Next-Generation Pharmacotherapies for Heart Failure: A Review.
|
Academic Article
|
Cytokines and matrix metalloproteinases as potential biomarkers in chronic heart failure.
|
Academic Article
|
Assessment of Cardiac Function--Basic Principles and Approaches.
|
Academic Article
|
Crossing Into the Next Frontier of Cardiac Extracellular Matrix Research.
|
Academic Article
|
Intracoronary delivery of recombinant TIMP-3 after myocardial infarction: effects on myocardial remodeling and function.
|
Academic Article
|
Institution of localized high-frequency electrical stimulation targeting early myocardial infarction: Effects on left ventricle function and geometry.
|
Academic Article
|
Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
|
Academic Article
|
Identification of a novel microRNA profile in pediatric patients with cancer treated with anthracycline chemotherapy.
|
Academic Article
|
Common pathways and communication between the brain and heart: connecting post-traumatic stress disorder and heart failure.
|
Academic Article
|
Heart failure as interstitial cancer: emergence of a malignant fibroblast phenotype.
|
Academic Article
|
Speckle-Tracking Echocardiography Enables Model-Based Identification of Regional Stiffness Indices in the Left Ventricular Myocardium.
|
Academic Article
|
The ubiquitin ligase WWP1 contributes to shifts in matrix proteolytic profiles and a myocardial aging phenotype with diastolic heart.
|
Academic Article
|
Application of Hybrid Matrix Metalloproteinase-Targeted and Dynamic 201Tl Single-Photon Emission Computed Tomography/Computed Tomography Imaging for Evaluation of Early Post-Myocardial Infarction Remodeling.
|
Academic Article
|
Focusing Heart Failure Research on Myocardial Fibrosis to Prioritize Translation.
|
Academic Article
|
Racial difference in atrial size and extracellular matrix homeostatic response to hypertension: Is this a potential mechanism of reduced atrial fibrillation in African Americans?
|
Academic Article
|
Cytokine Signaling and Matrix Remodeling Pathways Associated with Cardiac Sarcoidosis Disease Activity Defined Using FDG PET Imaging.
|
Academic Article
|
Ubiquitin ligase Wwp1 gene deletion attenuates diastolic dysfunction in pressure-overload hypertrophy.
|
Academic Article
|
Regional heterogeneity in determinants of atrial matrix remodeling and association with atrial fibrillation vulnerability postmyocardial infarction.
|
Academic Article
|
Ensemble machine learning model identifies patients with HFpEF from matrix-related plasma biomarkers.
|
Academic Article
|
Interpretable machine learning predicts cardiac resynchronization therapy responses from personalized biochemical and biomechanical features.
|
Academic Article
|
Tissue inhibitor of metalloproteinase-4 deletion in mice impacts maternal cardiac function during pregnancy and postpartum.
|
Academic Article
|
The Pathology of Primary Mitral?Regurgitation: The Matrix Is at the Heart of the Matter.
|